HEADER TRANSPORT PROTEIN 02-OCT-13 4C9H TITLE STRUCTURE OF YEAST MITOCHONDRIAL ADP/ATP CARRIER ISOFORM 2 INHIBITED TITLE 2 BY CARBOXYATRACTYLOSIDE (P212121 CRYSTAL FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP, ATP CARRIER PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP/ATP TRANSLOCASE 2, ADENINE NUCLEOTIDE TRANSLOCATOR 2, COMPND 5 ANT 2, PETITE COLONIES PROTEIN 9, ADP-ATP CARRIER ISOFORM 2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: WB12; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PYES3 KEYWDS MITOCHONDRIAL CARRIER, ADP/ATP CARRIER, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.J.RUPRECHT,A.M.HELLAWELL,M.HARDING,P.G.CRICHTON,A.J.MCCOY, AUTHOR 2 E.R.S.KUNJI REVDAT 4 20-DEC-23 4C9H 1 REMARK REVDAT 3 12-FEB-14 4C9H 1 JRNL REVDAT 2 05-FEB-14 4C9H 1 JRNL REVDAT 1 22-JAN-14 4C9H 0 JRNL AUTH J.J.RUPRECHT,A.M.HELLAWELL,M.HARDING,P.G.CRICHTON,A.J.MCCOY, JRNL AUTH 2 E.R.S.KUNJI JRNL TITL STRUCTURES OF YEAST MITOCHONDRIAL ADP/ATP CARRIERS SUPPORT A JRNL TITL 2 DOMAIN-BASED ALTERNATING-ACCESS TRANSPORT MECHANISM JRNL REF PROC.NATL.ACAD.SCI.USA V. 111 E426 2014 JRNL REFN ISSN 0027-8424 JRNL PMID 24474793 JRNL DOI 10.1073/PNAS.1320692111 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.251 REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 567 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8391 - 5.0588 0.99 2943 136 0.2462 0.2646 REMARK 3 2 5.0588 - 4.0263 1.00 2815 154 0.2283 0.2657 REMARK 3 3 4.0263 - 3.5206 1.00 2785 138 0.2585 0.2938 REMARK 3 4 3.5206 - 3.2002 1.00 2778 139 0.2779 0.3161 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.01 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4551 REMARK 3 ANGLE : 0.826 6148 REMARK 3 CHIRALITY : 0.042 687 REMARK 3 PLANARITY : 0.002 740 REMARK 3 DIHEDRAL : 17.495 1725 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C9H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1290058616. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11939 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.840 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.61000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C9G REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5, 10MM SODIUM CITRATE, REMARK 280 50MM AMMONIUM SULFATE, 8% T-BUTANOL, 23.5% PEG600. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.67700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.53050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.10150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.53050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.67700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.10150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 ASN A 4 REMARK 465 ALA A 5 REMARK 465 GLN A 6 REMARK 465 VAL A 7 REMARK 465 LYS A 8 REMARK 465 THR A 9 REMARK 465 PRO A 10 REMARK 465 LEU A 11 REMARK 465 PRO A 12 REMARK 465 PRO A 13 REMARK 465 ALA A 14 REMARK 465 PRO A 15 REMARK 465 ALA A 16 REMARK 465 PRO A 17 REMARK 465 LYS A 18 REMARK 465 LYS A 19 REMARK 465 GLU A 20 REMARK 465 LYS A 160 REMARK 465 SER A 161 REMARK 465 SER A 162 REMARK 465 LYS A 163 REMARK 465 LYS A 164 REMARK 465 GLY A 165 REMARK 465 GLY A 166 REMARK 465 PRO A 216 REMARK 465 LEU A 217 REMARK 465 LEU A 218 REMARK 465 LEU A 219 REMARK 465 THR A 220 REMARK 465 GLY A 221 REMARK 465 SER A 222 REMARK 465 LEU A 223 REMARK 465 GLU A 224 REMARK 465 GLY A 225 REMARK 465 SER A 226 REMARK 465 PHE A 227 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 ASN B 4 REMARK 465 ALA B 5 REMARK 465 GLN B 6 REMARK 465 VAL B 7 REMARK 465 LYS B 8 REMARK 465 THR B 9 REMARK 465 PRO B 10 REMARK 465 LEU B 11 REMARK 465 PRO B 12 REMARK 465 PRO B 13 REMARK 465 ALA B 14 REMARK 465 PRO B 15 REMARK 465 ALA B 16 REMARK 465 PRO B 17 REMARK 465 LYS B 18 REMARK 465 LYS B 19 REMARK 465 GLU B 20 REMARK 465 SER B 21 REMARK 465 ASN B 22 REMARK 465 PHE B 23 REMARK 465 SER B 161 REMARK 465 SER B 162 REMARK 465 LYS B 163 REMARK 465 LYS B 164 REMARK 465 GLY B 165 REMARK 465 PRO B 216 REMARK 465 LEU B 217 REMARK 465 LEU B 218 REMARK 465 LEU B 219 REMARK 465 THR B 220 REMARK 465 GLY B 221 REMARK 465 SER B 222 REMARK 465 LEU B 223 REMARK 465 GLU B 224 REMARK 465 GLY B 225 REMARK 465 SER B 226 REMARK 465 PHE B 227 REMARK 465 MET B 310 REMARK 465 ILE B 311 REMARK 465 LEU B 312 REMARK 465 PHE B 313 REMARK 465 GLY B 314 REMARK 465 LYS B 315 REMARK 465 LYS B 316 REMARK 465 PHE B 317 REMARK 465 LYS B 318 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 21 OG REMARK 470 PHE A 23 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 24 CG CD1 CD2 REMARK 470 ASP A 64 CG OD1 OD2 REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 ARG A 168 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 175 CG OD1 OD2 REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 LYS A 182 CG CD CE NZ REMARK 470 LEU A 214 CG CD1 CD2 REMARK 470 LEU A 228 CG CD1 CD2 REMARK 470 SER A 230 OG REMARK 470 PHE A 231 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 318 CG CD CE NZ REMARK 470 LEU B 24 CG CD1 CD2 REMARK 470 ASP B 64 CG OD1 OD2 REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 LYS B 110 CG CD CE NZ REMARK 470 LYS B 118 CG CD CE NZ REMARK 470 LYS B 178 CG CD CE NZ REMARK 470 LYS B 179 CG CD CE NZ REMARK 470 LEU B 214 CG CD1 CD2 REMARK 470 LEU B 228 CG CD1 CD2 REMARK 470 SER B 230 OG REMARK 470 PHE B 231 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 214 61.03 -115.86 REMARK 500 LEU B 214 63.93 -113.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 CARDIOLIPIN (CDL): CARDIOLIPIN ACYL CHAINS ARE MODELLED IN REMARK 600 PART REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CDL A 800 REMARK 610 CDL A 801 REMARK 610 CDL A 802 REMARK 610 CDL B 800 REMARK 610 CDL B 801 REMARK 610 CDL B 802 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CXT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDL B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CM5 A 1319 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C9G RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP-ATP CARRIER ISOFORM 2 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (C2221 CRYSTAL FORM) REMARK 900 RELATED ID: 4C9J RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP-ATP CARRIER ISOFORM 3 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (P212121 CRYSTAL FORM) REMARK 900 RELATED ID: 4C9Q RELATED DB: PDB REMARK 900 STRUCTURE OF YEAST MITOCHONDRIAL ADP/ATP CARRIER ISOFORM 3 REMARK 900 INHIBITED BY CARBOXYATRACTYLOSIDE (P21 CRYSTAL FORM) DBREF 4C9H A 1 318 UNP P18239 ADT2_YEAST 1 318 DBREF 4C9H B 1 318 UNP P18239 ADT2_YEAST 1 318 SEQRES 1 A 318 MET SER SER ASN ALA GLN VAL LYS THR PRO LEU PRO PRO SEQRES 2 A 318 ALA PRO ALA PRO LYS LYS GLU SER ASN PHE LEU ILE ASP SEQRES 3 A 318 PHE LEU MET GLY GLY VAL SER ALA ALA VAL ALA LYS THR SEQRES 4 A 318 ALA ALA SER PRO ILE GLU ARG VAL LYS LEU LEU ILE GLN SEQRES 5 A 318 ASN GLN ASP GLU MET LEU LYS GLN GLY THR LEU ASP ARG SEQRES 6 A 318 LYS TYR ALA GLY ILE LEU ASP CYS PHE LYS ARG THR ALA SEQRES 7 A 318 THR GLN GLU GLY VAL ILE SER PHE TRP ARG GLY ASN THR SEQRES 8 A 318 ALA ASN VAL ILE ARG TYR PHE PRO THR GLN ALA LEU ASN SEQRES 9 A 318 PHE ALA PHE LYS ASP LYS ILE LYS ALA MET PHE GLY PHE SEQRES 10 A 318 LYS LYS GLU GLU GLY TYR ALA LYS TRP PHE ALA GLY ASN SEQRES 11 A 318 LEU ALA SER GLY GLY ALA ALA GLY ALA LEU SER LEU LEU SEQRES 12 A 318 PHE VAL TYR SER LEU ASP TYR ALA ARG THR ARG LEU ALA SEQRES 13 A 318 ALA ASP SER LYS SER SER LYS LYS GLY GLY ALA ARG GLN SEQRES 14 A 318 PHE ASN GLY LEU ILE ASP VAL TYR LYS LYS THR LEU LYS SEQRES 15 A 318 SER ASP GLY VAL ALA GLY LEU TYR ARG GLY PHE LEU PRO SEQRES 16 A 318 SER VAL VAL GLY ILE VAL VAL TYR ARG GLY LEU TYR PHE SEQRES 17 A 318 GLY MET TYR ASP SER LEU LYS PRO LEU LEU LEU THR GLY SEQRES 18 A 318 SER LEU GLU GLY SER PHE LEU ALA SER PHE LEU LEU GLY SEQRES 19 A 318 TRP VAL VAL THR THR GLY ALA SER THR CYS SER TYR PRO SEQRES 20 A 318 LEU ASP THR VAL ARG ARG ARG MET MET MET THR SER GLY SEQRES 21 A 318 GLN ALA VAL LYS TYR ASP GLY ALA PHE ASP CYS LEU ARG SEQRES 22 A 318 LYS ILE VAL ALA ALA GLU GLY VAL GLY SER LEU PHE LYS SEQRES 23 A 318 GLY CYS GLY ALA ASN ILE LEU ARG GLY VAL ALA GLY ALA SEQRES 24 A 318 GLY VAL ILE SER MET TYR ASP GLN LEU GLN MET ILE LEU SEQRES 25 A 318 PHE GLY LYS LYS PHE LYS SEQRES 1 B 318 MET SER SER ASN ALA GLN VAL LYS THR PRO LEU PRO PRO SEQRES 2 B 318 ALA PRO ALA PRO LYS LYS GLU SER ASN PHE LEU ILE ASP SEQRES 3 B 318 PHE LEU MET GLY GLY VAL SER ALA ALA VAL ALA LYS THR SEQRES 4 B 318 ALA ALA SER PRO ILE GLU ARG VAL LYS LEU LEU ILE GLN SEQRES 5 B 318 ASN GLN ASP GLU MET LEU LYS GLN GLY THR LEU ASP ARG SEQRES 6 B 318 LYS TYR ALA GLY ILE LEU ASP CYS PHE LYS ARG THR ALA SEQRES 7 B 318 THR GLN GLU GLY VAL ILE SER PHE TRP ARG GLY ASN THR SEQRES 8 B 318 ALA ASN VAL ILE ARG TYR PHE PRO THR GLN ALA LEU ASN SEQRES 9 B 318 PHE ALA PHE LYS ASP LYS ILE LYS ALA MET PHE GLY PHE SEQRES 10 B 318 LYS LYS GLU GLU GLY TYR ALA LYS TRP PHE ALA GLY ASN SEQRES 11 B 318 LEU ALA SER GLY GLY ALA ALA GLY ALA LEU SER LEU LEU SEQRES 12 B 318 PHE VAL TYR SER LEU ASP TYR ALA ARG THR ARG LEU ALA SEQRES 13 B 318 ALA ASP SER LYS SER SER LYS LYS GLY GLY ALA ARG GLN SEQRES 14 B 318 PHE ASN GLY LEU ILE ASP VAL TYR LYS LYS THR LEU LYS SEQRES 15 B 318 SER ASP GLY VAL ALA GLY LEU TYR ARG GLY PHE LEU PRO SEQRES 16 B 318 SER VAL VAL GLY ILE VAL VAL TYR ARG GLY LEU TYR PHE SEQRES 17 B 318 GLY MET TYR ASP SER LEU LYS PRO LEU LEU LEU THR GLY SEQRES 18 B 318 SER LEU GLU GLY SER PHE LEU ALA SER PHE LEU LEU GLY SEQRES 19 B 318 TRP VAL VAL THR THR GLY ALA SER THR CYS SER TYR PRO SEQRES 20 B 318 LEU ASP THR VAL ARG ARG ARG MET MET MET THR SER GLY SEQRES 21 B 318 GLN ALA VAL LYS TYR ASP GLY ALA PHE ASP CYS LEU ARG SEQRES 22 B 318 LYS ILE VAL ALA ALA GLU GLY VAL GLY SER LEU PHE LYS SEQRES 23 B 318 GLY CYS GLY ALA ASN ILE LEU ARG GLY VAL ALA GLY ALA SEQRES 24 B 318 GLY VAL ILE SER MET TYR ASP GLN LEU GLN MET ILE LEU SEQRES 25 B 318 PHE GLY LYS LYS PHE LYS HET CXT A 401 51 HET CDL A 800 26 HET CDL A 801 43 HET CDL A 802 44 HET CM5 A1319 34 HET CXT B 401 51 HET CDL B 800 27 HET CDL B 801 44 HET CDL B 802 45 HETNAM CXT CARBOXYATRACTYLOSIDE HETNAM CDL CARDIOLIPIN HETNAM CM5 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE HETSYN CDL DIPHOSPHATIDYL GLYCEROL; BIS-(1,2-DIACYL-SN-GLYCERO-3- HETSYN 2 CDL PHOSPHO)-1',3'-SN-GLYCEROL HETSYN CM5 5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D- HETSYN 2 CM5 GLUCOPYRANOSIDE; CYMAL-5 FORMUL 3 CXT 2(C31 H46 O18 S2) FORMUL 4 CDL 6(C81 H156 O17 P2 2-) FORMUL 7 CM5 C23 H42 O11 HELIX 1 1 SER A 21 GLN A 60 1 40 HELIX 2 2 GLY A 69 GLY A 82 1 14 HELIX 3 3 VAL A 83 ARG A 88 5 6 HELIX 4 4 GLY A 89 GLY A 116 1 28 HELIX 5 5 LYS A 118 GLU A 121 5 4 HELIX 6 6 GLY A 122 ALA A 157 1 36 HELIX 7 7 GLY A 172 GLY A 185 1 14 HELIX 8 8 GLY A 192 LEU A 214 1 23 HELIX 9 9 LEU A 228 SER A 245 1 18 HELIX 10 10 SER A 245 THR A 258 1 14 HELIX 11 11 GLY A 267 GLY A 280 1 14 HELIX 12 12 VAL A 281 LYS A 286 5 6 HELIX 13 13 GLY A 287 PHE A 313 1 27 HELIX 14 14 LEU B 24 GLN B 60 1 37 HELIX 15 15 GLY B 69 GLY B 82 1 14 HELIX 16 16 VAL B 83 ARG B 88 5 6 HELIX 17 17 GLY B 89 ARG B 96 1 8 HELIX 18 18 ARG B 96 GLY B 116 1 21 HELIX 19 19 LYS B 118 GLU B 121 5 4 HELIX 20 20 GLY B 122 ALA B 157 1 36 HELIX 21 21 GLY B 172 GLY B 185 1 14 HELIX 22 22 GLY B 192 LEU B 214 1 23 HELIX 23 23 LEU B 228 SER B 245 1 18 HELIX 24 24 SER B 245 THR B 258 1 14 HELIX 25 25 GLY B 267 GLY B 280 1 14 HELIX 26 26 VAL B 281 LYS B 286 5 6 HELIX 27 27 GLY B 287 GLN B 309 1 23 SITE 1 AC1 7 ARG A 96 LYS A 108 SER A 141 GLY A 199 SITE 2 AC1 7 ARG A 204 ASP A 249 ARG A 252 SITE 1 AC2 6 TRP A 87 ARG A 88 GLY A 89 ASN A 90 SITE 2 AC2 6 THR A 91 ILE A 174 SITE 1 AC3 11 ILE A 51 GLY A 69 ILE A 70 LEU A 71 SITE 2 AC3 11 PHE A 285 LYS A 286 GLY A 287 CYS A 288 SITE 3 AC3 11 GLY A 289 ALA A 290 CDL B 801 SITE 1 AC4 12 ARG A 191 GLY A 192 PHE A 193 LEU A 194 SITE 2 AC4 12 VAL A 198 LEU A 248 GLY A 267 ALA A 268 SITE 3 AC4 12 PHE A 269 LEU B 194 PHE B 269 CDL B 802 SITE 1 AC5 11 ARG B 96 ASN B 104 LYS B 108 GLY B 199 SITE 2 AC5 11 ILE B 200 TYR B 203 ARG B 204 PHE B 208 SITE 3 AC5 11 SER B 245 ASP B 249 ARG B 252 SITE 1 AC6 7 TRP B 87 ARG B 88 GLY B 89 ASN B 90 SITE 2 AC6 7 THR B 91 LEU B 173 ILE B 174 SITE 1 AC7 14 CDL A 801 CM5 A1319 ILE B 51 GLY B 69 SITE 2 AC7 14 ILE B 70 LEU B 71 PHE B 285 LYS B 286 SITE 3 AC7 14 GLY B 287 CYS B 288 GLY B 289 ALA B 290 SITE 4 AC7 14 ILE B 292 LEU B 293 SITE 1 AC8 14 LEU A 194 CDL A 802 LEU B 143 PHE B 144 SITE 2 AC8 14 ALA B 187 TYR B 190 ARG B 191 GLY B 192 SITE 3 AC8 14 LEU B 194 VAL B 198 MET B 255 GLY B 267 SITE 4 AC8 14 ALA B 268 PHE B 269 SITE 1 AC9 8 GLU A 120 GLU A 279 VAL A 281 GLY A 282 SITE 2 AC9 8 SER A 283 LEU B 71 LYS B 75 CDL B 801 CRYST1 67.354 98.203 105.061 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014847 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010183 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009518 0.00000 MTRIX1 1 -0.994400 -0.105300 0.001800 -0.25540 1 MTRIX2 1 0.105400 -0.994400 0.004600 -2.23560 1 MTRIX3 1 0.001300 0.004800 1.000000 -0.29210 1